Evoxac (Cevimeline Hydrochloride) for Sjögren’s Syndrome
Overview Evoxac is approved by the U.S. Food and Drug Administration (FDA) for the treatment of dry mouth symptoms in people with Sjögren’s syndrome. Evoxac is also known by its drug name, cevimeline hydrochloride.